4th Quarter - Report

VENABLE LLP for ENDO PHARMACEUTICALS INC

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Oversight of implementation of the American Invents Act. Issues relating to patent settlements. Legislation relating to abusive patent litigation.

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. H.R. 486 - Stop Tampering of Prescription Pills Act of 2013. Issues relating to Medicare Part D rebates. Issues relating to health information technology. H.R. 1919 - Safeguarding Americas Pharmaceuticals Act of 2013.

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1919 (113th), H.R. 486 (113th)

Taxation/Internal Revenue Code TAX

Issues relating to incentives for life sciences research. H.R. 523/S. 232 - Protect Medical Innovation Act of 2013.

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 232 (113th), H.R. 523 (113th)

Pharmacy PHA

Issues related to tamper resistant formulation of pharmaceutical drugs. The Life Sciences Jobs and Investment Act

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.